EPHB4-directed CAR T cells demonstrated enhanced cytotoxicity, proliferation, and cytokine secretion <i>in vitro</i>, and superior tumor control with increased T cell infiltration in Rh30-TACS tumors <i>in vivo</i> compared with Rh30 tumors. This evidence concerns the gene EPHB4 and neoplasm.